As much as we hate to start out 2022 with more discussion about Covid-19, recent developments concerning the virus have prompted this much-needed update.
We’ll start with the not-so-great news. On November 24, 2021, a report of a new variant of the covid-19 virus found in South Africa was sent to the World Health Organization (WHO). By December 1, 2021, the new variant, now called OMICRON, had made its way to US shores.
What We Know About OMICRON
At the time this article was written, little was known about OMICRON, although the world’s top health experts are working diligently to learn more about the variant. We do know that the OMICRON variant is more likely to spread more easily than other variants. We also know that vaccines are still the best protection against all variants of the virus although breakthrough infections in people who are fully vaccinated are likely to occur. However, those who are vaccinated are not likely to experience severe illness, hospitalization, or death due to the virus.
The Latest CDC Guidelines
New research has prompted the CDC to shorten the number of days one should quarantine or isolate following exposure or diagnosis of covid-19. Those exposed to or diagnosed with covid-19 now only need to isolate or quarantine for five days followed up with strict mask-wearing for five more days.
New Treatment Receives Emergency Authorization from FDA
Despite the latest variant developments, there is still good news regarding covid-19 treatments. A new oral treatment by Pfizer has received an emergency authorization of use by the Food and Drug Administration.
Paxlovid is a tablet developed for the treatment of mild to moderate covid-19 in adults and children aged 12 and up. The new drug is available by prescription only and should be administered as soon as possible after a positive diagnosis, within five days of onset of virus symptoms. Paxlovid works by inhibiting a SARS-Cov-2 protein from replicating. The treatment is administered in three tablets taken orally twice a day for five days. Paxlovid is not approved for pre-exposure or post-exposure prevention.
Vaccines are still the best protection against covid-19. Stop by EliteCare today to receive your Moderna vaccine.